Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants
Samit Ganguly,Andrea N. Edginton,Jacqueline G. Gerhart,Michael Cohen-Wolkowiez,Rachel G. Greenberg,Daniel Gonzalez,Daniel K. Benjamin Jr,Christoph Hornik,Kanecia Zimmerman,Phyllis Kennel,Rose Beci,Chi Dang Hornik,Gregory L. Kearns,Matthew Laughon,Ian M. Paul,Janice Sullivan,Kelly Wade,Paula Delmore,Perdita Taylor-Zapata,June Lee,Ravinder Anand,Gaurav Sharma,Gina Simone,Kim Kaneshige,Lawrence Taylor,Thomas Green,Anand Kantak,Judy Ohlinger,Mike Horgan,Susan Boynton,Eric C. Eichenwald,Karen Jones,David J. Durand,Jeanette Asselin,Antonio Arrieta,Kathy Shea,Kelly Wade,Tonia Morrison,Beverly S. Brozanski,Robyn Baker,Joern-Hendrik Weitkamp,Millie Nannie,Pablo Sanchez,Shirley Montanye,John van den Anker,Elaine Williams,P. Brian Smith,Margarita Bidegain,Daniel K. Benjamin Jr,Sandy Grimes,William MacKendrick,Sue Wolf,Brenda Poindexter,Leslie Dawn Wilson,Lisa M. Castro,Ann Harris,Venkataraman Balaraman,Robyn Morse,Maynard Rasmussen,Kathy Arnell,Gloria Valencia,Sara Higgerson,Michele Walsh,Arlene Zadell,Claire M. Roane,Neil Finer,Edmund V. Capparelli,Wade Rich,David Burchfield,Cindy Miller,Janice E. Sullivan,Gwendolyn Pierce,Varsha Bhatt-Mehta,Ron Dechert,Robert M. Ward,JoAnn Narus,Mathew Bizzaro,Monica Konstantino,
DOI: https://doi.org/10.1007/s40262-021-01046-6
2021-06-22
Clinical Pharmacokinetics
Abstract:Meropenem is a broad-spectrum carbapenem antibiotic approved by the US Food and Drug Administration for use in pediatric patients, including treating complicated intra-abdominal infections in infants < 3 months of age. The impact of maturation in glomerular filtration rate and tubular secretion by renal transporters on meropenem pharmacokinetics, and the effect on meropenem dosing, remains unknown. We applied physiologically based pharmacokinetic (PBPK) modeling to characterize the disposition of meropenem in preterm and term infants.
pharmacology & pharmacy